|Gebot||75,34 x 9000|
|Briefkurs||75,54 x 30000|
|Tagesspanne||75,34 - 75,76|
|52-Wochen-Spanne||71,20 - 89,02|
|Beta (5 J., monatlich)||0,72|
|Kurs-Gewinn-Verhältnis (roll. Hochrechn.)||29,72|
|EPS (roll. Hochrechn.)||N/A|
|Erwartete Dividende & Rendite||2,59 (3,42%)|
|Ex-Dividendendatum||21. Sept. 2023|
NORTHAMPTON, MA / ACCESSWIRE / November 9, 2022 / Medtronic In this episode, Mira Sahney, president of the Pelvic Health business at Medtronic, explains how incontinence is a debilitating condition that needs more attention and treatment. The company's ...
CECP's CEO Investor Forum, the only platform that brings CEOs and investors together to discuss Long-Term Plans, hosted three CEOs from the world's largest medtech companies-Abbott (NYSE:ABT), Medtronic (NYSE:MDT), and Intuitive Surgical (NASDAQ:ISRG).
Medtronic Stroke is a leading cause of death and disability around the world, but only a fraction of people who suffer a stroke get treatment in time.